The principles of treatment for tuberculous pleurisy in the fullpurulent stage are: on the basis of aggressive systemic anti-tuberculosis treatment, to remove the segregation and fluid accumulation, to maximize the restoration of lung function, and to prevent the chronicity of inflammation. Tuberculous pleurisy in the fibrino-purulent stage is characterized by the presence of a large number of compartments in the chest cavity, and drainage is often not clear. Due to the blockage of fibrin and the change of effusion from thin fluid in the acute stage to jelly-like at this stage, the entire effusion cannot be aspirated by simple puncture, but only a small parcel of effusion at the puncture site, or even no effusion at all. So this stage is often used to inject fibrinolytic enzymes, such as urokinase, into the chest cavity to dissolve the fibrin and extract the pleural fluid. urokinase can be injected several times and act many times, and its common side effects include fever and irritation of the pleura causing mild pain. In recent years many thoracic surgeons try to use surgery, or open chest, or minimally invasive thoracoscopic surgery in the fibro-purulent stage to remove the fibrin and jelly-like exudate from the chest cavity, and find that the compressed lung tissue can be quickly reopened, with the advantages of simple operation, short operation time, precise efficacy, less bleeding and fast recovery of lung function. This operation is called thoracic contouring, and the authors have used thoracic contouring to treat more than 60 cases of tuberculous abscess chest (fibrous purulent stage) in recent years, and achieved satisfactory results.